
Take the intake
Answer a short set of health questions. Five minutes, on your phone, no waiting room.
Compounded semaglutide and tirzepatide from US-licensed pharmacies. Same active ingredients used in Wegovy and Zepbound. Up to ~20% body-weight loss reported in clinical trials.
Prescription treatment only if appropriate after a licensed clinician reviews your health history.

Answer a short set of health questions. Five minutes, on your phone, no waiting room.

A US-licensed physician reads your file, then prescribes the right protocol. You only pay if approved.

Filled by a US-licensed pharmacy and shipped unmarked packaging.

Shown to support meaningful weight loss.

Built for greater average weight-loss results.
Your clinician, your medication, your refills, your support — one monthly price, no hidden costs.
Estimate uses 15.2% as a simple trial-benchmark example. This is not a promise or prediction. Your results may vary.
A simple, supported way to take control of your weight-loss care.
You can — if your insurance covers GLP-1s for weight loss. Most don't. The ones that do often require:
Prior authorization (4–8 weeks of paperwork).
No weeks of insurance paperwork before you can get moving.
BMI documentation, often from multiple appointments.
Complete your intake online instead of chasing documentation across appointments.
Step therapy — fail other meds first before they'll cover this.
A U.S.-licensed clinician reviews your history and decides if treatment is appropriate.
Then you're still paying $300–$500 a month in copays.
Competitively priced care, reviewed and shipped in days — not weeks.
Maro is cash-pay and competitively priced. Same active ingredients as Wegovy and Zepbound — reviewed and shipped in days, not weeks.
Semaglutide and tirzepatide are distinct medications with separate clinical-trial benchmark results.
These outcomes are reported across many weeks, not days. GLP-1 treatment is built around steady progress over time.
Most treatment plans start lower and increase over time to support tolerability and a more sustainable routine.
Published results are tied to specific medications and doses, which is why semaglutide 2.4 mg and tirzepatide 15 mg are shown separately.
Average percent body-weight change reported in selected clinical studies.
Source: Wilding JPH et al., NEJM 2021; Jastreboff AM et al., NEJM 2022. Individual results may vary.
Maro patients lose weight gradually, on plans written by a U.S.-licensed clinician and adjusted month over month. Not a 30-day transformation — a routine that holds.
Easy-to-follow plans that fit your life and goals.
Transparent pricing with no surprise fees.
Plans built for consistency and long-term results.
GLP-1 medications help regulate appetite and fullness signals. Some also slow gastric emptying, which may help you feel full longer. Your clinician can explain how a specific option may fit your health history.
A licensed clinician reviews your BMI, health history, current medications, and safety considerations before deciding whether prescription treatment is appropriate.
Results vary. GLP-1 treatment is typically evaluated over months, not days, and is paired with dose guidance, nutrition habits, and ongoing check-ins.
Common side effects can include nausea, constipation, diarrhea, stomach discomfort, or appetite changes, especially around dose increases. Your clinician will review risks before treatment.
Maro is designed around follow-up support, dose guidance, and messaging access so your plan can be adjusted if clinically appropriate.
If treatment is prescribed, fulfillment and refills are handled through licensed pharmacy partners with discreet, unbranded delivery.